I replied to a question in another thread which required me to do some more reading about pseudoprogression.
Pseudoprogression With Immunotherapy Treatment for Cancer (verywellhealth.com)
[7] The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy | Cancer Biology & Medicine (cancerbiomed.org)
With that in mind, even if we were given regular updates, they would almost be meaningless until 3-6 months after first treatment. So, I'm not overly concerned if we don't receive any further updates until there has been sufficient time for cohort 5 and/or even cohort 6 to have moved beyond pseudoprogression. (Which yes, will possibly be late this year if not early next year! I think best case scenario would be September/October this year.)
So, the next question that comes to mind is: Will we see pseudoprogression when onCARlytics is combined with Blincyto?
With some (very) quick research, I didn't find an answer however it seems pseudoprogression can occur with CAR-T treatments so maybe it will occur for Blincyto.
Obviously there's been a few hints that news will be coming soon, and the recent increase of investor presentations and investor marketing/communications from the company seems to serve as a bit of a look at us (and while you're looking, we'll drop some news), however, the news may not be for a CF33 related treatment. Not sure what to make of it all other than, drug development and clinical trials are not for the short term &/or impatient investor.
- Forums
- ASX - By Stock
- IMU
- Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting, page-146
-
- There are more pages in this discussion • 159 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $431.8M |
Open | High | Low | Value | Volume |
5.9¢ | 5.9¢ | 5.6¢ | $1.037M | 17.94M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 1882949 | 5.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.9¢ | 399643 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 1874329 | 0.058 |
9 | 1728227 | 0.057 |
23 | 4466894 | 0.056 |
27 | 3648665 | 0.055 |
8 | 305000 | 0.054 |
Price($) | Vol. | No. |
---|---|---|
0.059 | 1360 | 1 |
0.060 | 2622845 | 17 |
0.061 | 773907 | 4 |
0.062 | 2227969 | 6 |
0.063 | 243179 | 3 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online